Phase 2 Neutropenia Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Phase 2
Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
Solid TumorsChemotherapy-induced NeutropeniaAdolescent+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences132 enrolled1 locationNCT06926751
Recruiting
Phase 2
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 2
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
NeutropeniaHematological Malignancy
West Virginia University55 enrolled1 locationNCT05537896
Recruiting
Phase 2
Luspatercept for Clonal Cytopenias of Uncertain Significance
ThrombocytopeniaNeutropeniaAnemia+2 more
Weill Medical College of Cornell University50 enrolled1 locationNCT06788691
Recruiting
Phase 2
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN
Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital1,076 enrolled1 locationNCT07187908
Recruiting
Phase 2
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy
Chemotherapy-induced Neutropenia
Sun Yat-sen University97 enrolled1 locationNCT06857292
Not Yet Recruiting
Phase 2
Trial of prophylactic GCSF (white cell growth factor) use to prevent low white cell counts in people re-exposed to clozapine
NeutropeniaSchizophrenia
University of Queensland20 enrolled2 locationsACTRN12618001830280
Completed
Phase 2
Paracetamol in febrile neutropenia feasibility study
Infection: febrile neutropenia after intensive chemotherapy
Malaghan Institute of Medical Research50 enrolled1 locationACTRN12613000601730